Gene knockout vectors

Wednesday, 08 February, 2006 | Supplied by: Merck


Sigma-Aldrich has introduced TargeTron vectors designed for use with the TargeTron gene knockout system. The vectors enhance the capabilities and increase the flexibility of the system providing researchers with a targeted method to knock out multiple genes in prokaryotic organisms, to generate knockouts without using selection or by using removable selection and to produce knockouts in organisms lacking a source of T7 RNA polymerase.

The Vector pACD4K-C-loxP is a linearised E.coli expression vector containing loxP sites to facilitate the removal of the kanamycin marker. This enables the generation of multiple, site-specific knockouts in the same bacterial chromosome.

The pACD4 (no selectable marker) contains four linearised vectors lacking the kanamycin RAM marker. Additionally, each vector has an A, C, G or T in the delta + 1 position.

This facilitates proper base pairing of the group II intron RNA for different target site designs resulting in more efficient precursor RNA splicing to form active RNPs.

This vector set allows researchers to generate prokaryotic knockouts when selection cannot be used. The reach of the knockout system has been increased with the introduction of the pAR1219 vector. This provides a source of T7 RNA polymerase when co-transformed with pACD4K-C.

Adding an external source of T7 RNA polymerase allows for the creation of knockouts in organisms such as salmonella typhimurium and shigella flexneri as well as in non-DE3 strains of E.coli.

Online: www.sigmaaldrich.com
Phone: 02 9841 0555
Related Products

Takara Bio PrimeCap T7 RNA Polymerase (low dsRNA)

The polymerase is designed to remove both the technical and financial barriers to the successful...

Maxwell Biosystems MaxTwo high-density microelectrode array (HD-MEA) system

The next-generation multiwell HD-MEA captures high-quality signals at subcellular resolution from...

Enzo Life Sciences PROTEOSTAT Protein refolding and aggregation sensing kit

The kit includes a comprehensive set of optimised screening reagents and conditions that...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd